TR200503396T1 - Yeni, amorf bir formda valsartan. - Google Patents

Yeni, amorf bir formda valsartan.

Info

Publication number
TR200503396T1
TR200503396T1 TR2005/03396T TR200503396T TR200503396T1 TR 200503396 T1 TR200503396 T1 TR 200503396T1 TR 2005/03396 T TR2005/03396 T TR 2005/03396T TR 200503396 T TR200503396 T TR 200503396T TR 200503396 T1 TR200503396 T1 TR 200503396T1
Authority
TR
Turkey
Prior art keywords
valsartan
amorphous form
new
preparation
pharmaceutical composition
Prior art date
Application number
TR2005/03396T
Other languages
English (en)
Inventor
Bani Parthasaradhi Reddy
Kura Rathnakar Reddy
Rapolu Raji Reddy
Dasari Muralidhara Reddy
Original Assignee
Hetero Drugs Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Drugs Limited filed Critical Hetero Drugs Limited
Publication of TR200503396T1 publication Critical patent/TR200503396T1/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu buluş, valsartanın yeni bir amorf formu ile, bunun hazırlanması için bir usulle ve bunu içeren farmasötik bir bileşim ile ilgilidir.
TR2005/03396T 2003-03-31 2003-03-31 Yeni, amorf bir formda valsartan. TR200503396T1 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000096 WO2004087681A1 (en) 2003-03-31 2003-03-31 A novel amorphous form of valsartan

Publications (1)

Publication Number Publication Date
TR200503396T1 true TR200503396T1 (tr) 2006-08-21

Family

ID=33104945

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2005/03396T TR200503396T1 (tr) 2003-03-31 2003-03-31 Yeni, amorf bir formda valsartan.

Country Status (4)

Country Link
US (1) US20050165075A1 (tr)
AU (1) AU2003223106A1 (tr)
TR (1) TR200503396T1 (tr)
WO (1) WO2004087681A1 (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7199144B2 (en) 2003-04-21 2007-04-03 Teva Pharmaceuticals Industries, Ltd. Process for the preparation of valsartan and intermediates thereof
WO2004094392A1 (en) 2003-04-21 2004-11-04 Teva Pharmaceutical Industries Ltd. Process for the preparation of valsartan
EP1844025A1 (en) * 2005-01-11 2007-10-17 Teva Pharmaceutical Industries Ltd. Process for preparing amorphous valsartan
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
WO2008035364A2 (en) * 2006-06-23 2008-03-27 Usv Limited Process for the preparation of micronized valsartan
WO2010091169A2 (en) * 2009-02-04 2010-08-12 Dr. Reddy's Laboratories Ltd. Preparation of valsartan
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000050I1 (de) * 1990-02-19 2007-11-08 Novartis Ag Acylverbindungen
CN1137887C (zh) * 2000-04-07 2004-02-11 常州四药制药有限公司 一种合成缬沙坦的改进方法
DE60135560D1 (de) * 2000-07-19 2008-10-09 Novartis Ag Valsartan salze

Also Published As

Publication number Publication date
WO2004087681A1 (en) 2004-10-14
US20050165075A1 (en) 2005-07-28
AU2003223106A1 (en) 2004-10-25

Similar Documents

Publication Publication Date Title
IL237323A0 (en) Antibodies to m-CSF, their preparation and their uses
SE0301653D0 (sv) Novel compounds
SE0302811D0 (sv) Novel compounds
DE602005027899D1 (de) Mundpflegezusammensetzung mit dem extrakt von unoxidierter kamelie
TR200102029T2 (tr) 1-Heterosiklil ikameli diarilaminler.
IL229778A0 (en) Antibodies against ir-igf, their use and preparations that include them
DK1791571T3 (da) Radiofluorinerede peptider
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
EA200701707A1 (ru) Пиразолопиримидины
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
DE602006016303D1 (de) 3,4-dihydro-2H-benzoÄ1,4Üoxazin- und 3,4-dihydro-2H-benzoÄ1,4Üthiazin-VERBINDUNGEN ALS ALPHA2C-ADRENOREZEPTOR-ANTAGONISTEN
EA200702586A1 (ru) Кристаллические модификации пираклостробина
CR8559A (es) Pirazolopirimidinas
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
TW200602076A (en) O, O'-amidomalonate and N, O-amidomalonate platinum complexes
ATE393764T1 (de) Polymorphe formen von valsartan
MA30042B1 (fr) Composes calcilytiques
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
FR2849381B1 (fr) Composition cosmetique, solaire et bio-bronzante
TR201901390T4 (tr) Demodikoza karşı madde.
CY1110891T1 (el) Παραγωγα 6-ετεροαρυλπυριδοϊνδολονης, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη αγωγη
TW200744612A (en) New combination
AU2003240822A8 (en) Antibodies that specifically bind to neurokinin b
MY134026A (en) ?-carboline derivatives and its pharmaceutical use against depression and anxiety
ITMI20030385A1 (it) Composizione cosmetica comprendente poliisoprene.